ArticleJournal for immunotherapy of cancer2026

Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling.

Victoria Roulstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.